Navigation Links
Environmental Tectonics Corporation Announces Placement of Two Monoplace Chambers at St. John Wound Center; First Computer-controlled Hyperbaric Chambers in Oklahoma
Date:12/8/2008

SOUTHAMPTON, Pa., Dec. 8 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (Amex: ETC) ("ETC" or the "Company") BioMedical Division today announced the recent installation of two BARA-MED(R)XD Monoplace hyperbaric oxygen chambers in the St. John Wound Center, Tulsa, Oklahoma, USA. The state-of-the-art monoplace chambers are the first computer-controlled hyperbaric chambers to be placed into service in Oklahoma.

Hyperbaric oxygen (HBO) chambers offer advanced care for chronic wounds by administering pure oxygen under increased atmospheric pressure, which speeds and enhances the body's natural ability to heal. This allows for an increased amount of oxygen to be carried by the blood system, offering multiple benefits to the organs and tissues of the body. Additionally, HBO improves the benefit of certain antibiotics, activates white blood cells and promotes the healing process in chronic wounds.

St. John Health System operates hospitals in Tulsa, Owasso, Sapulpa and Bartlesville. A fifth affiliate hospital is under construction in Broken Arrow, Okla., with completion scheduled for 2010.

"The staff of the St. John Wound Center is committed to the treatment of the whole patient, not just the wound," said Dr. Lam Le, Medical Director of the St. John Wound Center. "We work closely with specialists and primary care physicians to provide a complete care plan for optimal wound healing to address the specific needs of each patient."

Dr. Le noted that individuals with slow healing or chronic wounds may be candidates for wound therapy. Chronic wounds are characterized by tissue that does not heal in a timely manner, usually between two to four weeks.

ETC manufactures the industry's most technically advanced hyperbaric chamber. The BARA-MED(R) XD includes a 4th generation computer based operating system which controls and records chamber activity. ETC chambers continue to remain the leader in providing a patient friendly pressurization alternative (Smooth Ride(TM)) that minimizes complications due to middle ear and sinus barotraumas without increasing compression time.

Gene Davis, President of ETC's BioMedical Division, commented, "With placement of these chambers in Oklahoma, we are seeing an increased footprint of sales growth in the Southern United States."

ETC is witnessing an increased demand from hospitals and wound care clinics that recognize that our chambers are ready to meet the demands of EMR (Electronic Medical Records). ETC plans to continue to supply our customers with most well-designed and scientifically advanced products in a competitive market.

ETC designs, develops, installs and maintains aircrew training systems (aeromedical, tactical combat and general), disaster management training systems and services, entertainment products, sterilizers (steam and gas), environmental testing products, hyperbaric chambers and related products for domestic and international customers.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by Lenfest, (ii) the potential delisting of the Company's common stock from the American Stock Exchange as a result of the Company's failure to comply with the AMEX listing standards, (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, including our outstanding litigation with Disney; (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10K for the fiscal year ended February 29, 2008, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock. The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

    Contact:  Duane D. Deaner, CFO
    Tel: 215-355-9100 (ext. 1203)
    Fax: 215-357-4000
    ETC - Internet Home Page:http://www.etcusa.com


'/>"/>
SOURCE Environmental Tectonics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. National Geographic Uses Air Filtration in Bid To Be an Energy, Environmental Leader
2. Bio-Tec Environmental Introduces Their New Plastic Additive Showing 45% Biodegradation of Plastics in Just 14 Days
3. Environmental Power Corporation and Organix, Inc. Establish Alliance to Produce High Value Soil Amendment Products
4. Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division
5. Global Agricultural and Environmental Diagnostics Market to Reach $2.4 Billion by 2012, According to New Report by Global Industry Analysts
6. Environmental Tectonics Corporations Simulation Division Receives New ADMS Contract from Netherlands Institute for Safety
7. Environmental Tectonics Corporations BioMedical Systems Division Places Two Monoplace Chambers at East Orange (NJ) General Hospital
8. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
9. SRNLs microbes useful for for environmental cleanup and oil recovery
10. High-quality DNA/RNA from Microorganisms in Environmental Samples
11. Environmental Tectonics Corporation Announces a Multiple Sale of Hyperbaric Monoplace Chambers to Comprehensive Healthcare Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, ... microbial test has received AOAC Research Institute approval 061601. , “This is another ... year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, ... of the Supplyframe Design Lab . Located in Pasadena, Calif., the Design ... of how hardware projects are designed, built and brought to market. , The ...
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
Breaking Biology Technology:
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
(Date:5/9/2016)... , UAE, May 9, 2016 ... it comes to expanding freedom for high net worth ... Even in today,s globally connected world, there is still ... system could ever duplicate sealing your deal with a ... second passports by taking advantage of citizenship via investment ...
Breaking Biology News(10 mins):